(Total Views: 339)
Posted On: 07/28/2021 4:35:55 PM
Post# of 35
$ARCT News Article - Arcturus Announces Regulatory Approval to Proceed with Phase 2 Study of ARCT-810 mRNA Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency https://marketwirenews.com/news-releases/arct...25589.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
